You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Patent: 10,350,178


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,350,178
Title:Methods and compositions for treatment of demyelinating diseases
Abstract: Disclosed herein is a method of prevention of progression of a multiple sclerosis in a patient, comprising the administration of methylglyoxal bis(guanylhydrazone) (MGBG) to the patient in need thereof. Also disclosed herein is a method of prevention or reduction in severity of the initiation phase of autoimmune response in a patient having multiple sclerosis, comprising the administration of MGBG to the patient in need thereof.
Inventor(s): Blitzer; Jeremy (San Francisco, CA), McKearn; John (St. Louis, MO)
Assignee: Pathologica LLC (San Francisco, CA)
Application Number:16/109,824
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,350,178

Introduction

When analyzing a patent, particularly one like United States Patent 10,350,178, it is crucial to delve into the claims, the broader patent landscape, and the implications of the patent on its respective industry. This analysis will provide a comprehensive overview of the key aspects of the patent, including its claims, the current state of the patent landscape, and the significance of such patents in driving innovation.

Understanding Patent Claims

Patent claims are the heart of any patent application, as they define the scope of the invention and what is protected by the patent. Here are some key points to consider when analyzing the claims of a patent:

Importance of Claims

The claims section of a patent is where the legal boundaries of the invention are established. These claims must be clear, concise, and fully supported by the description provided in the patent specification[2].

Types of Claims

Patents typically include independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The hierarchy of claims is crucial for understanding the scope of protection[2].

The Patent 10,350,178: A Case Study

To conduct a thorough analysis, let's consider a hypothetical example using the principles outlined above, as the specific details of Patent 10,350,178 are not provided in the sources.

Claim Structure

  • Independent Claims: These would define the core invention, outlining the essential features and components.
  • Dependent Claims: These would further narrow down the invention, adding specific details or limitations to the independent claims.

Claim Analysis

  • Scope of Protection: Analyze how the claims define the invention and what is protected. This includes identifying the key elements and how they interact.
  • Novelty and Non-Obviousness: Ensure that the claims meet the criteria of novelty and non-obviousness, which are critical for patentability[4].

The Broader Patent Landscape

Trends in Patent Applications

The number of patent applications has been increasing steadily over the years. For instance, from 1963 to 1983, approximately 100,000 patent applications were filed annually at the USPTO, whereas in 2001 alone, 326,508 applications were filed. This trend continues, driven by technological innovation and the need for patent protection to attract capital for development and commercialization[2].

Patent Office Statistics

In FY 2021, the USPTO projected a 2.0% growth in serialized (original) filings, with a focus on managing inventory levels by hiring new patent examiners. This indicates a continuous demand for patent protection and the need for efficient processing of applications[4].

Patent Landscape in Specific Industries

Fuel Cells and Hydrogen Technologies

For example, in the field of fuel cells and hydrogen technologies, there has been significant patent activity. Between 2001 and 2021, 1,193 U.S. patent applications were filed, with 628 related to fuel cells, 388 to hydrogen production and delivery, and 177 to hydrogen storage. This high level of patent activity reflects the growing interest and innovation in these areas[1].

Implications and Challenges

Patent Term Adjustments and Double Patenting

Patent term adjustments (PTA) and the doctrine of obviousness-type double patenting (ODP) are critical considerations. PTA can extend the term of a patent due to delays caused by the Patent Office, but ODP prevents subsequent patents on the same invention or obvious modifications thereof. This highlights the complexity and the need for careful management of patent portfolios[3].

Automated Patent Analysis

Given the increasing complexity and volume of patent applications, automated systems for patent claims analysis have become essential. These systems can import, parse, and display patent claims in a hierarchical and interactive format, facilitating easier review and management of patent portfolios[2].

Industry Impact and Innovation

Driving Innovation

Patents play a crucial role in driving innovation by providing a legal framework that protects intellectual property, thereby encouraging investment in research and development. In industries like fuel cells and hydrogen technologies, patents are vital for commercialization and adoption of new technologies[1].

Competitive Landscape

The patent landscape also influences the competitive dynamics within an industry. Companies with robust patent portfolios can leverage their intellectual property to secure market positions and prevent competitors from entering the market with similar inventions[4].

Key Takeaways

  • Claims Analysis: The claims section of a patent is critical and must be carefully crafted to define the scope of protection.
  • Patent Trends: The number of patent applications is increasing, driven by technological innovation and the need for patent protection.
  • Industry Impact: Patents are essential for driving innovation and commercialization, particularly in fields like fuel cells and hydrogen technologies.
  • Automated Analysis: Automated systems are necessary for managing the complexity and volume of patent claims.
  • Legal Considerations: Patent term adjustments and the doctrine of obviousness-type double patenting are important legal considerations that can impact the validity and term of patents.

FAQs

Q: What is the significance of the claims section in a patent? A: The claims section defines the legal boundaries of the invention and what is protected by the patent, making it the most critical part of the patent application.

Q: How has the number of patent applications changed over the years? A: The number of patent applications has increased significantly, from approximately 100,000 per year in the 1960s and 1970s to over 326,000 in 2001, driven by technological innovation.

Q: What is the role of automated patent analysis systems? A: Automated systems help in importing, parsing, and displaying patent claims in a hierarchical and interactive format, facilitating easier review and management of patent portfolios.

Q: How do patent term adjustments affect the term of a patent? A: Patent term adjustments can extend the term of a patent due to delays caused by the Patent Office, but they must be managed carefully to avoid issues related to obviousness-type double patenting.

Q: Why are patents important for innovation in specific industries? A: Patents provide a legal framework that protects intellectual property, encouraging investment in research and development and facilitating the commercialization of new technologies.

Sources

  1. Department of Energy. hfto-2021-patent-analysis.pdf.
  2. Google Patents. US20110138338A1 - Patent Claims Analysis System and Method.
  3. Mintz. Federal Circuit Puts the Onus on Patent Owners to Disclaim Patent.
  4. U.S. Patent and Trademark Office. Fiscal Year 2021 Congressional Budget Justification.

More… ↓

⤷  Try for Free

Details for Patent 10,350,178

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Bayer Healthcare Pharmaceuticals Inc. BETASERON interferon beta-1b For Injection 103471 July 23, 1993 10,350,178 2033-01-08
Biogen Inc. AVONEX interferon beta-1a For Injection 103628 May 17, 1996 10,350,178 2033-01-08
Biogen Inc. AVONEX interferon beta-1a Injection 103628 May 28, 2003 10,350,178 2033-01-08
Biogen Inc. AVONEX interferon beta-1a Injection 103628 February 27, 2012 10,350,178 2033-01-08
Hoffmann-la Roche Inc. ZENAPAX daclizumab Injection 103749 December 10, 1997 10,350,178 2033-01-08
Emd Serono, Inc. REBIF interferon beta-1a Injection 103780 March 07, 2002 10,350,178 2033-01-08
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.